According to the concept of our development strategy, one of the basic objectives in the further development of our company has been building and foundation of a modern factory for manufacture of medicines and other pharmaceutical-chemical products REPLEK FARM LTD, that was completed in 2001. Designed, built and equipped in accordance with the most recent requirements of Good Manufacturing Practice as well as the strictest requirements for protection of human environment, today the factory is a complete, operative, highly-standardized wholeness which manufactures more than 150 medicines, registered in our country and abroad, in accordance with the strictest requirements for quality and safety of medicines.
The effects of the operation of the state-of-the-art technologically implemented in the operation of the factory shall result not only in widening of the product range but also in achieving higher cost-effectiveness.
A few words from Dr. Ivan Tudzarov, General Manager of REPLEK FARM LTD
“Company’s core business, since 2001, is development, design and production of generic medicines in different pharmaceutical therapeutic categories, as oral dosage forms: tablets, capsules and oral solutions, as well as medicines for topical use (creams, ointments, solutions), by the ReplekFarm -pharmaceutical factory, a daughter of the REPLEK AD share holding company.
ReplekFarm LTD, a state-of-the-art pharmaceutical factory, apart of being designed, built and equipped in accordance with GMP standards with modern, semi-automatic and automatic machinery, was and still is a place of challenge for the most skilled personal in this field in the country.
Having established a quite strong product portfolio on the domestic market, constantly implementing the strict and current international regulations for production, quality control and product approvals, building step by step good contractual and business relations with suppliers and especially improving the clients, customers and patients relationships, the highly educated and experienced team of ambitious professionals have succeed sustainable results at the domestic market.
Product portfolio consists of 150 different generic medicines, some of them developed and as first-class generics (first entrance after patent expiration). They are listed in 11 different therapeutic categories, among which 10 best sell medicines lead as: anti-platelet (Clopidogrel); lipid lowering (Atorvastatin, Simvastatin); atypical antipsychotic (risperidone, olanzapine); anti-infective (Azithromycin; Clarythromycin, Ciprofloxacin). There are also medicines in different dosage forms for treatment of a limentary tract and metabolism diseases; anti-hypertensive medicines; analgesics and dermatological products.
Export activities, as well as contract marketing, contract manufacturing and tender businesses on foreign markets are becoming growing factor in our current operations, so the company’s development plans are mostly focused on further international market expansion.”